Exoskeleton Market at a Tipping Point: From $3.5B to $64B by 2034
The exoskeleton market is no longer a niche technology segment — it’s a rapidly maturing industry with projections that demand attention from every safety-conscious organization.
Three Market Forecasts, One Direction: Up
Multiple independent research firms have published projections in 2026, all pointing to explosive growth:
- Fortune Business Insights (2026): $3.52B in 2026 → $64.23B by 2034, CAGR 43.7%
- Data Bridge Market Research (2025): $590.52M in 2025 → $9.6B by 2033, CAGR 41.7%
- ABI Research (2018): $192M → $3B by 2028 — now surpassed by actual growth
The Four Key Drivers
1. The Gray Ceiling
Workers aged 55+ make up 25% of the U.S. labor force (TimeTrex 2026). Exoskeletons extend the working lives of experienced employees while reducing injury risk.
2. Labor Shortage
U.S. manufacturing faces a 2 million worker shortage (ManufacturingTomorrow). Every injury prevented directly impacts production capacity.
3. Regulatory Pressure
OSHA ergonomic enforcement via the General Duty Clause is up 27% over two years (JD Supra, July 2026). Exoskeletons are recognized as good-faith abatement evidence.
4. Proven ROI
Ford’s EksoVest reduced shoulder injuries by 83% across 15 plants. The total economic burden of MSK injuries is $100B annually. Passive exoskeletons with 6-18 month payback periods are a sound investment.
What This Means for Buyers
The market is moving from “should we try exoskeletons?” to “which program fits our operations?” Early adopters building programs now will have a competitive advantage in workforce retention and injury reduction.
Sources: Fortune Business Insights (2026); Data Bridge Market Research (2025); ABI Research / Assembly Magazine.